4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-046015
Director sold 177,135 shares at an average $38.25 ($6,775,149)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PIMSTONE SIMON N. Director | 2022-08-12 | Sale | −43,135 | $37.91 | $1,635,248 | 140,000 | D: show line 1 in the form |
| PIMSTONE SIMON N. Director | 2022-08-12 | Sale | −47,000 | $38.60 | $1,814,200 | 93,000 | D: show line 2 in the form |
| PIMSTONE SIMON N. Director | 2022-08-12 | Sale | −1,000 | $39.15 | $39,150 | 92,000 | D: show line 3 in the form |
| PIMSTONE SIMON N. Director | 2022-08-15 | Sale | −33,942 | $37.76 | $1,281,650 | 58,058 | D: show line 4 in the form |
| PIMSTONE SIMON N. Director | 2022-08-16 | Sale | −32,058 | $38.29 | $1,227,501 | 26,000 | D: show line 5 in the form |
| PIMSTONE SIMON N. Director | 2022-08-16 | Sale | −20,000 | $38.87 | $777,400 | 6,000 | D: show line 6 in the form |
| Open-market sales · 177,135 sh · avg $38.25 · $6,775,149 | |||||||
Loading xslF345X03/doc4.xml…